Avadel Pharmaceuticals plc - Ordinary Share (AVDL) analyst actions
Rating and price-target actions on AVDL in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the AVDL overview →
1 measured AVDL analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Avadel Pharmaceuticals Reiterates 2025 Guidance as it Reports Fourth Quarter and Full Year 2024 Financial Results | Press release | +3.97% | -3.21% |
Keep exploring
More AVDL: earnings → · SEC filings → · AVDL overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Heron Therapeutics, Inc. (HRTX) | 247 | -0.34% | 42% |
| Intra-Cellular Therapies Inc. (ITCI) | 247 | -0.04% | 44% |
| Cumberland Pharmaceuticals Inc. (CPIX) | 245 | 0.00% | 49% |
| electroCore, Inc. (ECOR) | 245 | 0.00% | 47% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.